News dal mondo
15
Mag
European Commission outlines plans to mobilize EMA to diversify supply chains
he European Commission has adopted a Global Health Resilience Initiative that gives EMA a role in diversifying global supply chains. Supply chain diversification is one of nine flagship initiatives proposed in the document. Believing that diversified and well-integrated global supply chains help build resilience, the Commission plans to work with global partners to address concentrations of production capabilities responsible for systemic risks. As part of the efforts, the Commission will mobilize EMA and the network of EU national regulatory authorities to support collaborative regulatory pathways. The goal is to support the development and manufacturing of key health products based on mutual interest. The Commission also plans to work with partner countries on regulatory aspects of health science, genome, and biodata repositories. [European Commission]
15
Mag
US FDA’s New AI-Informed Inspection Pilot and What It Means for Industry
We have written on this blog about FDA’s modernization agenda from several angles lately—from...
15
Mag
EU Regulators discuss new pharma legislation, AI, and more
A panel of European regulators answered questions during a town panel discussion at RAPS Euro Convergence...
15
Mag
US FDA official details top observations from QMSR inspections
The top observations identified in Form 483 reports from inspections conducted under the recently implemented...
13
Mag
Deal on tackling EU shortages of essential medicines
Prioritise investment in EU manufacturing capacity to increase autonomy “Buy European”...
le ultime news
23 Apr
Regulatory considerations for pharmaceutical excipient selection
21 Apr
TGA clarifies therapeutic goods are unaffected by chemical production and import ban
20 Apr
US FDA Draft Guidance on Establishing Impurity Specifications for Antibiotics
20 Apr
Alfasigma cede a Fine Foods il 100% di Sofar
17 Apr
Sostanze stupefacenti, il Ministero aggiorna le tabelle: inclusa la classe dei Nitazeni tra le sostanze vietate
17 Apr
Gemmato: 'Iran. Rschio carenze farmaci, legge delega per rafforzare produzione nazionale. Convocherò tavolo'
16 Apr
Farmaci salvavita, l’Italia dipende all’80% da Cina e India. Gemmato: «Poche settimane di autonomia in caso di crisi»
16 Apr
Guerre e filiera vulnerabile: l’industria farmaceutica italiana cerca le contromisure